Citations (99)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Mauro Giovanni Carta, Pasquale Paribello, Annalisa Anastasia, Domenico De Berardis, Antonio Egidio Nardi & Michele Fornaro. (2018) Pharmacological management of depression in patients with multiple sclerosis. Expert Opinion on Pharmacotherapy 19:14, pages 1533-1540.
Read now
Read now
Marianna Vitkova, Zuzana Gdovinova, Jaroslav Rosenberger, Jarmila Szilasiova, Pavol Mikula, Roy E. Stewart, Johan W. Groothoff & Jitse P. van Dijk. (2018) Is Poor Sleep Quality Associated With Greater Disability in Patients With Multiple Sclerosis?. Behavioral Sleep Medicine 16:2, pages 106-116.
Read now
Read now
Thomas G Gilberthorpe, Kara E O’Connell, Alison Carolan, Eli Silber, Peter A Brex, Naomi A Sibtain & Anthony S David. (2017) The spectrum of psychosis in multiple sclerosis: a clinical case series. Neuropsychiatric Disease and Treatment 13, pages 303-318.
Read now
Read now
Chiara C. Incerti, Ornella Argento, Valerio Pisani, Giuseppe Magistrale, Ugo Sabatello, Carlo Caltagirone & Ugo Nocentini. (2017) A more in-depth interpretation of MMPI-2 in MS patients by using Harris and Lingoes subscales. Applied Neuropsychology: Adult 24:5, pages 439-445.
Read now
Read now
Bhasker Sriramoju, Rupinder K Kanwar & Jagat R Kanwar. (2015) Neurobehavioral burden of multiple sclerosis with nanotheranostics. Neuropsychiatric Disease and Treatment 11, pages 2675-2689.
Read now
Read now
Pinar G. Ozdemir, Aysel Milanlioglu, Murat Boysan, Vedat Cilingir, Nuri Aydin & Abdullah Atli. (2015) Relations between mood characteristics, circadian preferences, and functionality in multiple sclerosis. International Journal of Psychiatry in Clinical Practice 19:2, pages 148-154.
Read now
Read now
Alessandra Lugaresi, Maria di Ioia, Daniela Travaglini, Erika Pietrolongo, Eugenio Pucci & Marco Onofrj. (2013) Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis. Neuropsychiatric Disease and Treatment 9, pages 893-914.
Read now
Read now
Rebecca R King & Jeffrey P Reiss. (2013) The epidemiology and pathophysiology of pseudobulbar affect and its association with neurodegeneration. Degenerative Neurological and Neuromuscular Disease 3, pages 23-31.
Read now
Read now
Saeed Talebzadeh Nick, Charles Roberts, Seth Billiodeaux, Debra Elliott Davis, Behrouz Zamanifekri, Mohammad Ali Sahraian, Nadejda Alekseeva, Sai Munjampalli, Joann Roberts & Alireza Minagar. (2012) Multiple sclerosis and pain. Neurological Research 34:9, pages 829-841.
Read now
Read now
Keith C Hayes. (2011) Impact of extended-release dalfampridine on walking ability in patients with multiple sclerosis. Neuropsychiatric Disease and Treatment 7, pages 229-239.
Read now
Read now
Goranka Petriček, Mladenka Vrcić-Keglević, Djurdjica Lazić & Lucija Murgić. (2011) How to deal with a crying patient? A study from a primary care setting in Croatia, using the ‘critical incident technique’. European Journal of General Practice 17:3, pages 153-159.
Read now
Read now
Articles from other publishers (88)
Viviana Lo Buono, Francesco Corallo, Lilla Bonanno, Deborah Pria, Marcella Di Cara, Rosanna Palmeri, Giangaetano D'Aleo, Carmela Rifici, Edoardo Sessa, Silvia Marino & Maria Cristina De Cola. (2023) Psychological symptoms in Multiple Sclerosis and the role of marital status: results from a retrospective single-center study. Multiple Sclerosis and Related Disorders 79, pages 105051.
Crossref
Crossref
Xuesong Huang, Ying Huang & Bing Hu. (2023) Melatonin Treatment of Circadian Rhythm Sleep-Wake Disorder in Obese Children Affects the Brain-Derived Neurotrophic Factor Level. Neuropediatrics 54:04, pages 260-265.
Crossref
Crossref
Jennifer HsuAmanda PleinScott B. Mathis. (2023) Neuropsychiatric Manifestations of Tumefactive Demyelinating Lesion. American Journal of Psychiatry Residents' Journal 18:4, pages 9-12.
Crossref
Crossref
Ulysse M.C.C. Thivisol, Michele D. Binder, Anthony J. Hannan & Terence Y. Pang. (2023) Loss of Tyro3 causes anxiety-relevant behavioural changes in female mice. Brain Research 1807, pages 148319.
Crossref
Crossref
Marialaura Di Tella, Marinella Clerico & Lorys Castelli. (2021) Associations between socioemotional alterations, quality of life, and social functioning in multiple sclerosis: A scoping review. Current Psychology 42:13, pages 11143-11154.
Crossref
Crossref
Karina Maciak, Angela Dziedzic & Joanna Saluk. (2022)
Possible role of the
NLRP3
inflammasome and the gut–brain axis in multiple sclerosis‐related depression
. The FASEB Journal 37:1.
Crossref
Crossref
David Myland Kaufman, Howard L. Geyer, Mark J. Milstein & Jillian L. Rosengard. 2023. Kaufman's Clinical Neurology for Psychiatrists. Kaufman's Clinical Neurology for Psychiatrists
344
364
.
Melanie Filser, Axel Buchner, Gereon Rudolf Fink, Stefan M. Gold & Iris-Katharina Penner. (2022) The manifestation of affective symptoms in multiple sclerosis and discussion of the currently available diagnostic assessment tools. Journal of Neurology 270:1, pages 171-207.
Crossref
Crossref
Carolina Alves Rodrigues, Mafalda Delgado Soares, Gustavo Jesus & Filipa Ladeira. (2022) Major depressive disorder: A rare presentation of multiple sclerosis. Psychiatry Research Case Reports 1:2, pages 100030.
Crossref
Crossref
Omid Mirmosayyeb, Mohammadjavad Naderi, Sina Raeisi, Narges Ebrahimi, Elham Moases Ghaffary, Alireza Afshari-Safavi, Mahdi Barzegar & Vahid Shaygannejad. (2022) Hearing loss among patients with multiple sclerosis (PwMS): A systematic review and meta-analysis. Multiple Sclerosis and Related Disorders 62, pages 103754.
Crossref
Crossref
Joanna Dymecka, Rafał Gerymski, Rafał Tataruch & Mariola Bidzan. (2022) Sense of Coherence and Health-Related Quality of Life in Patients with Multiple Sclerosis: The Role of Physical and Neurological Disability. Journal of Clinical Medicine 11:6, pages 1716.
Crossref
Crossref
Maria Grazia Maggio, Maria Chiara Stagnitti, Patrizia Calatozzo, Serena Formica, Desiree Latella, Alfredo Manuli, Giuseppe Avena, Valentina Oddo & Rocco Salvatore Calabrò. (2022) Cognitive rehabilitation outcomes in patients with Multiple sclerosis: Preliminary data about the potential role of personality traits. Multiple Sclerosis and Related Disorders 58, pages 103533.
Crossref
Crossref
Athina-Maria Aloizou, Georgia Pateraki, Konstantinos Anargyros, Vasileios Siokas, Christos Bakirtzis, Ioannis Liampas, Anastasia Nousia, Grigorios Nasios, Markos Sgantzos, Eleni Peristeri & Efthimios Dardiotis. (2021) Transcranial magnetic stimulation (TMS) and repetitive TMS in multiple sclerosis. Reviews in the Neurosciences 32:7, pages 723-736.
Crossref
Crossref
Wan-Yu Hsu, Annika Anderson, William Rowles, Katherine E. Peters, Vicki Li, Katie L. Stone, Liza H. Ashbrook, Amy A. Gelfand & Riley M. Bove. (2021) Effects of melatonin on sleep disturbances in multiple sclerosis: A randomized, controlled pilot study. Multiple Sclerosis Journal - Experimental, Translational and Clinical 7:4, pages 205521732110487.
Crossref
Crossref
Aleksandar Stojanov, Slobodan Vojinovic, Jelena Stojanov, Marina Malobabic, Milos Stevic, Vuk Milosevic & Goran Stanojevic. (2021) Quality of sleep and fatigue in patients with the relapsing-remitting multiple sclerosis during the coronavirus disease-2019 pandemic. Clinical Neurology and Neurosurgery 205, pages 106640.
Crossref
Crossref
Bryan E. Davis, Lynsey Lakin, Cherie C. Binns, Keisha M. Currie & Mary R. Rensel. (2021) Patient and Provider Insights into the Impact of Multiple Sclerosis on Mental Health: A Narrative Review. Neurology and Therapy 10:1, pages 99-119.
Crossref
Crossref
Lynsey Lakin, Bryan E. Davis, Cherie C. Binns, Keisha M. Currie & Mary R. Rensel. (2021) Comprehensive Approach to Management of Multiple Sclerosis: Addressing Invisible Symptoms—A Narrative Review. Neurology and Therapy 10:1, pages 75-98.
Crossref
Crossref
Neda Ramezani, Fereshteh Ashtari, Elahe Abdi Bastami, Kimia Ghaderi, Sayed Mohsen Hosseini, Maryam Kazemi Naeini, Fatemeh Rajabi & Iman Adibi. (2021) Fear and anxiety in patients with multiple sclerosis during COVID-19 pandemic; report of an Iranian population. Multiple Sclerosis and Related Disorders 50, pages 102798.
Crossref
Crossref
Karina Maciak, Angela Dziedzic, Elzbieta Miller & Joanna Saluk-Bijak. (2021) miR-155 as an Important Regulator of Multiple Sclerosis Pathogenesis. A Review. International Journal of Molecular Sciences 22:9, pages 4332.
Crossref
Crossref
Madhav Chopra & Stephen Kataria. (2021) Multiple Sclerosis : A Review. International Journal of Scientific Research in Science and Technology, pages 193-211.
Crossref
Crossref
Simona Raimo, Gabriella Santangelo & Luigi Trojano. 2021. Disorders of Emotion in Neurologic Disease. Disorders of Emotion in Neurologic Disease
197
220
.
Carlos B. Tauil, Amanda D. da Rocha Lima, Breno B. Ferrari, Verônica A.G. da Silva, Adriel S. Moraes, Flávia M. da Silva, César A. Melo-Silva, Alessandro S. Farias, Carlos O. Brandão, M.B. dosSantos Leonilda & Leopoldo L. dos Santos-Neto. (2020) Depression and anxiety in patients with multiple sclerosis treated with interferon-beta or fingolimod: Role of indoleamine 2,3-dioxygenase and pro-inflammatory cytokines. Brain, Behavior, & Immunity - Health 9, pages 100162.
Crossref
Crossref
Maria Grazia Maggio, Marilena Foti Cuzzola, Desiree Latella, Federica Impellizzeri, Antonino Todaro, Giuseppe Rao, Alfredo Manuli & Rocco Salvatore Calabrò. (2020) How personality traits affect functional outcomes in patients with multiple sclerosis: A scoping review on a poorly understood topic. Multiple Sclerosis and Related Disorders 46, pages 102560.
Crossref
Crossref
Anca Florea, Helene Maurey, Melanie Le Sauter, Celine Bellesme, Caroline Sevin & Kumaran Deiva. (2019) Fatigue, depression, and quality of life in children with multiple sclerosis: a comparative study with other demyelinating diseases. Developmental Medicine & Child Neurology 62:2, pages 241-244.
Crossref
Crossref
Christos Bakirtzis, Ioannis Nikolaidis, Marina-Kleopatra Boziki, Artemios Artemiadis, Athina Andravizou, Lambros Messinis, Panagiotis Ioannidis & Nikolaos Grigoriadis. (2020) Cognitive Fatigability is Independent of Subjective Cognitive Fatigue and Mood in Multiple Sclerosis. Cognitive and Behavioral Neurology 33:2, pages 113-121.
Crossref
Crossref
Celeste Silveira, Renato Guedes, Diana Maia, Rosário Curral & Rui Coelho. (2019) Neuropsychiatric Symptoms of Multiple Sclerosis: State of the Art. Psychiatry Investigation 16:12, pages 877-888.
Crossref
Crossref
Sara ZareiIrvin MaldonadoLaura Franqui-DominguezCristina RubiYanibel Tapia RosaCristina Diaz-MartyGuadalupe CoronadoMarimer C. Rivera NievesGolnoush AkhlaghipourAngel Chinea. (2019) Impact of delayed treatment on exacerbations of multiple sclerosis among Puerto Rican patients. Surgical Neurology International 10, pages 200.
Crossref
Crossref
Robert Simpson, Sharon Simpson, Nitish Ramparsad, Margaret Lawrence, Jo Booth & Stewart W Mercer. (2019) Mindfulness-based interventions for mental well-being among people with multiple sclerosis: a systematic review and meta-analysis of randomised controlled trials. Journal of Neurology, Neurosurgery & Psychiatry 90:9, pages 1051-1058.
Crossref
Crossref
Maciej Wilski, Waldemar Brola & Maciej Tomczak. (2019) Health locus of control and mental health in patients with multiple sclerosis: Mediating effect of coping strategies. Research in Nursing & Health 42:4, pages 296-305.
Crossref
Crossref
Nilton dos Santos, Leonardo S. Novaes, Guilherme Dragunas, Jennifer R. Rodrigues, Wesley Brandão, Rosana Camarini, Jean Pierre Schatzmann Peron & Carolina Demarchi Munhoz. (2019) High dose of dexamethasone protects against EAE-induced motor deficits but impairs learning/memory in C57BL/6 mice. Scientific Reports 9:1.
Crossref
Crossref
Laura Mordillo-Mateos, Vanesa Soto-Leon, Marta Torres-Pareja, Diego Peinado-Palomino, Nuria Mendoza-Laiz, Carlos Alonso-Bonilla, Michele Dileone, Mario Rotondi, Juan Aguilar & Antonio Oliviero. (2019) Fatigue in Multiple Sclerosis: General and Perceived Fatigue Does Not Depend on Corticospinal Tract Dysfunction. Frontiers in Neurology 10.
Crossref
Crossref
Clare Coppock, Rebecca Adlington, Katrina Fisher & Maggie MacCormack. (2019) Evaluating a Tree of Life group for individuals with Multiple Sclerosis. Health Psychology Update 28:1, pages 4-13.
Crossref
Crossref
Štěpánka Machová & Eva Kadlecová. (2018) Mental symptoms in patients who suffer from multiple sclerosis. Psychiatrie pro praxi 19:3, pages 106-110.
Crossref
Crossref
Kanako Nakazawa, Takamasa Noda, Kanako Ichikura, Tomoko Okamoto, Yuji Takahashi, Takashi Yamamura & Kazuyuki Nakagome. (2018) Resilience and depression/anxiety symptoms in multiple sclerosis and neuromyelitis optica spectrum disorder. Multiple Sclerosis and Related Disorders 25, pages 309-315.
Crossref
Crossref
Dorian A. Lamis, Jameson K. Hirsch, Kelley C. Pugh, Raluca Topciu, Sheri A. Nsamenang, Andrew Goodman & Paul R. Duberstein. (2018) Perceived cognitive deficits and depressive symptoms in patients with multiple sclerosis: Perceived stress and sleep quality as mediators. Multiple Sclerosis and Related Disorders 25, pages 150-155.
Crossref
Crossref
Ivana Štětkářová, Alena Javůrková & Jaroslava Raudenská. (2018) Depression in multiple sclerosis. Neurologie pro praxi 19:2, pages 114-122.
Crossref
Crossref
Victoria M. Leavitt, Gabriella Tosto & Claire S. Riley. (2018) Cognitive phenotypes in multiple sclerosis. Journal of Neurology 265:3, pages 562-566.
Crossref
Crossref
Steven M. Bailey & Claire M. Rice. 2018. Progressive Multiple Sclerosis. Progressive Multiple Sclerosis
155
205
.
Nages Nagaratnam, Kujan Nagaratnam & Gary CheukNages Nagaratnam, Kujan Nagaratnam & Gary Cheuk. 2018. Geriatric Diseases. Geriatric Diseases
337
341
.
Brandon P. Moss, Mary R. Rensel & Carrie M. Hersh. (2017) Wellness and the Role of Comorbidities in Multiple Sclerosis. Neurotherapeutics 14:4, pages 999-1017.
Crossref
Crossref
Mirjam R. Heldner, Sigal Kaufmann-Ezra, Klemens Gutbrod, Corrado Bernasconi, Sandra Bigi, Verena Blatter, Heinrich P. Mattle, René M. Müri, Rajeev K. Verma & Christian P. Kamm. (2017) Behavioral Changes in Patients with Multiple Sclerosis. Frontiers in Neurology 8.
Crossref
Crossref
Ruth Murphy, Stefani O’Donoghue, Timothy Counihan, Colm McDonald, Peter A Calabresi, Mohammed AS Ahmed, Adam Kaplin & Brian Hallahan. (2017) Neuropsychiatric syndromes of multiple sclerosis. Journal of Neurology, Neurosurgery & Psychiatry 88:8, pages 697-708.
Crossref
Crossref
Sylviane Muller, Susana Brun, Frédérique René, Jérôme de Sèze, Jean-Philippe Loeffler & Hélène Jeltsch-David. (2017) Autophagy in neuroinflammatory diseases. Autoimmunity Reviews 16:8, pages 856-874.
Crossref
Crossref
Emily Koelmel, Abbey J. Hughes, Kevin N. Alschuler & Dawn M. Ehde. (2017) Resilience Mediates the Longitudinal Relationships Between Social Support and Mental Health Outcomes in Multiple Sclerosis. Archives of Physical Medicine and Rehabilitation 98:6, pages 1139-1148.
Crossref
Crossref
Samar S. Ayache & Moussa A. Chalah. (2017) Fatigue in multiple sclerosis – Insights into evaluation and management. Neurophysiologie Clinique/Clinical Neurophysiology 47:2, pages 139-171.
Crossref
Crossref
Susan L. Kasser, Amanda Goldstein, Phillip K. Wood & Jeremy Sibold. (2017) Symptom variability, affect and physical activity in ambulatory persons with multiple sclerosis: Understanding patterns and time-bound relationships. Disability and Health Journal 10:2, pages 207-213.
Crossref
Crossref
Moussa A. Chalah & Samar S. Ayache. (2017) Psychiatric event in multiple sclerosis: could it be the tip of the iceberg?. Revista Brasileira de Psiquiatria 39:4, pages 365-368.
Crossref
Crossref
Shengli Ma, Xue Rui, Peiyi Qi, Gangqiong Liu & Jing Yang. (2016) Sleep disorders in patients with multiple sclerosis in China. Sleep and Breathing 21:1, pages 149-154.
Crossref
Crossref
V.M. Lewis, K. Williams, C. KoKo, J. Woolmore, C. Jones & T. Powell. (2017) Disability, depression and suicide ideation in people with multiple sclerosis. Journal of Affective Disorders 208, pages 662-669.
Crossref
Crossref
Hans-Peter Kapfhammer. 2017. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
2693
2805
.
Nages Nagaratnam, Kujan Nagaratnam & Gary CheukNages Nagaratnam, Kujan Nagaratnam & Gary Cheuk. 2017. Geriatric Diseases. Geriatric Diseases
1
6
.
Sven Schippling, Paul O’Connor, Volker Knappertz, Christoph Pohl, Timon Bogumil, Gustavo Suarez, Stuart Cook, Massimo Filippi, Hans-Peter Hartung, Giancarlo Comi, Douglas R. Jeffery, Ludwig Kappos, Douglas S. Goodin & Barry Arnason. (2016) Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial. Journal of Neurology 263:7, pages 1418-1426.
Crossref
Crossref
Stacey Murray & Andrew Woo. (2015) Clinical experience with repository corticotropin injection in patients with multiple sclerosis experiencing mood changes with intravenous methylprednisolone: a case series. Therapeutic Advances in Neurological Disorders 9:3, pages 189-197.
Crossref
Crossref
David Satzer & David J Bond. (2016) Mania secondary to focal brain lesions: implications for understanding the functional neuroanatomy of bipolar disorder. Bipolar Disorders 18:3, pages 205-220.
Crossref
Crossref
Nadine LacroixM. serv. sM. serv. s, Normand BoucherPh.D.Ph.D. & Patrick VilleneuvePh.D.Ph.D.. (2016) Participation sociale et sclérose en plaques : Réalité particulière. Service social 62:2, pages 94.
Crossref
Crossref
Arnaud Francois, Julie Verite, Agnès Rioux Bilan, Thierry Janet, Frédéric Calon, Bernard Fauconneau, Marc Paccalin & Guylène Page. 2016. Molecules to Medicine with mTOR. Molecules to Medicine with mTOR
85
104
.
Sevan Hotier, David Maltete, Bertrand Bourre, Xavier Jegouzo, Valérie Bourgeois & Olivier Guillin. (2015) A manic episode with psychotic features improved by methylprednisolone in a patient with multiple sclerosis. General Hospital Psychiatry 37:6, pages 621.e1-621.e2.
Crossref
Crossref
Irit Gil-Ad, Ben H. Amit, Liat Hayardeni, Igor Tarasenko, Michal Taler, Ravit Uzan Gueta & Abraham Weizman. (2014) Effects of the Anti-Multiple Sclerosis Immunomodulator Laquinimod on Anxiety and Depression in Rodent Behavioral Models. Journal of Molecular Neuroscience 55:2, pages 552-560.
Crossref
Crossref
Luis Pintor Pérez, Roberto Sánchez González & Eva Baillés Lázaro. (2014) Treatment of Mood Disorders in Multiple Sclerosis. Current Treatment Options in Neurology 17:1.
Crossref
Crossref
H.-P. Kapfhammer. 2016. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
1
114
.
Mauro Giovanni Carta, Maria Francesca Moro, Giuseppina Trincas, Lorena Lorefice, Eleonora Cocco & Maria Giovanna Marrosu. 2015. Neuropsychiatric Symptoms of Inflammatory Demyelinating Diseases. Neuropsychiatric Symptoms of Inflammatory Demyelinating Diseases
65
74
.
Robert J Simpson, Gary McLean, Bruce Guthrie, Frances Mair & Stewart W Mercer. (2014) Physical and mental health comorbidity is common in people with multiple sclerosis: nationally representative cross-sectional population database analysis. BMC Neurology 14:1.
Crossref
Crossref
Timothy L. Vollmer, Michael J. Robinson, Richard C. Risser & Sandra K. Malcolm. (2014) A Randomized, Double-Blind, Placebo-Controlled Trial of Duloxetine for the Treatment of Pain in Patients with Multiple Sclerosis. Pain Practice 14:8, pages 732-744.
Crossref
Crossref
E. Rosti-Otajärvi, J. Ruutiainen, H. Huhtala & P. Hämäläinen. (2014) Relationship between subjective and objective cognitive performance in multiple sclerosis. Acta Neurologica Scandinavica 130:5, pages 319-327.
Crossref
Crossref
Hans-Peter Kapfhammer. (2014) Depressive und Angststörungen bei Patienten mit Epilepsie und Multipler Sklerose – eine Herausforderung für die nervenärztliche PraxisCoexistent depressive and anxiety disorders in epilepsy and multiple sclerosis: a challenge to neuropsychiatric practice. neuropsychiatrie 28:3, pages 142-150.
Crossref
Crossref
Sibel Gazioglu, Vildan Altunayoglu Cakmak, Evrim Ozkorumak, Nuray Can Usta, Can Ates & Cavit Boz. (2014) Personality Traits of Patients With Multiple Sclerosis and Their Relationship With Clinical Characteristics. Journal of Nervous & Mental Disease 202:5, pages 408-411.
Crossref
Crossref
Youssef Sidhom, Mouna Ben Djebara, Yosr Hizem, Istabrak Abdelkefi, Imen Kacem, Amina Gargouri & Riadh Gouider. (2014) Bipolar Disorder and Multiple Sclerosis: A Case Series. Behavioural Neurology 2014, pages 1-4.
Crossref
Crossref
Shaona Acharjee, Nausheen Nayani, Mio Tsutsui, Matthew N. Hill, Shalina S. Ousman & Quentin J. Pittman. (2013) Altered cognitive-emotional behavior in early experimental autoimmune encephalitis – Cytokine and hormonal correlates. Brain, Behavior, and Immunity 33, pages 164-172.
Crossref
Crossref
Ruth Ann Marrie & Heather Hanwell. (2013) General Health Issues in Multiple Sclerosis. CONTINUUM: Lifelong Learning in Neurology 19, pages 1046-1057.
Crossref
Crossref
Gökhan Sarısoy, Murat Terzi, Kübra Gümüş & Ozan Pazvantoğlu. (2013) Psychiatric symptoms in patients with multiple sclerosis. General Hospital Psychiatry 35:2, pages 134-140.
Crossref
Crossref
Eija Rosti-OtajärviPäivi Hämäläinen. (2012) Behavioural symptoms and impairments in multiple sclerosis: a systematic review and meta-analysis. Multiple Sclerosis Journal 19:1, pages 31-45.
Crossref
Crossref
C. Gasperini & S. Ruggieri. 2013. Aspetti psicologici nella sclerosi multipla. Aspetti psicologici nella sclerosi multipla
11
26
.
M. Falautano. 2013. Aspetti psicologici nella sclerosi multipla. Aspetti psicologici nella sclerosi multipla
115
123
.
Ibrahim A. Abdel-Hamid, Moheb M. Abdel-Razek & Tarek Anis. 2013. Premature Ejaculation. Premature Ejaculation
167
185
.
Claire M. Rice & Alastair Wilkins. 2013. Progressive Multiple Sclerosis. Progressive Multiple Sclerosis
147
186
.
Hanne Marie Bøe Lunde, Tommy F. Aae, William Indrevåg, Jan Aarseth, Bjørn Bjorvatn, Kjell-Morten Myhr & Lars Bø. (2012) Poor Sleep in Patients with Multiple Sclerosis. PLoS ONE 7:11, pages e49996.
Crossref
Crossref
Juan Gérvas, Raimundo Pastor-Sánchez & Mercedes Pérez-Fernández. (2012) Crying patients in General/Family Practice: incidence, reasons for encounter and health problems. Revista Brasileira de Medicina de Família e Comunidade 7:24, pages 171-176.
Crossref
Crossref
M. Yildiz. (2012) The impact of slower walking speed on activities of daily living in patients with multiple sclerosis. International Journal of Clinical Practice 66:11, pages 1088-1094.
Crossref
Crossref
Maria Skokou, Evanthia Soubasi & Philippos Gourzis. (2012) Depression in Multiple Sclerosis: A Review of Assessment and Treatment Approaches in Adult and Pediatric Populations. ISRN Neurology 2012, pages 1-6.
Crossref
Crossref
Nadejda Alekseeva, Felix Geller, James Patterson, Mary Fitz-Gerald, Rita Horton & Alireza Minagar. (2012) Urgent and Emergent Psychiatric Disorders. Neurologic Clinics 30:1, pages 321-344.
Crossref
Crossref
Chiara Luoni, Francesca Bisulli, Maria Paola Canevini, Giovambattista De Sarro, Cinzia Fattore, Carlo Andrea Galimberti, Giuliana Gatti, Angela La Neve, Giancarlo Muscas, Luigi Maria Specchio, Salvatore Striano & Emilio Perucca. (2011) Determinants of health-related quality of life in pharmacoresistant epilepsy: Results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments. Epilepsia 52:12, pages 2181-2191.
Crossref
Crossref
Minesh Kapadia & Boris Sakic. (2011) Autoimmune and inflammatory mechanisms of CNS damage. Progress in Neurobiology 95:3, pages 301-333.
Crossref
Crossref
Ana Caminero & Manuel Bartolomé. (2011) Sleep disturbances in multiple sclerosis. Journal of the Neurological Sciences 309:1-2, pages 86-91.
Crossref
Crossref
M.P. Cid, A.A. Vilcaes, L.L. Rupil, N.A. Salvatierra & G.A. Roth. (2011) Participation of the GABAergic system on the glutamate release of frontal cortex synaptosomes from Wistar rats with experimental autoimmune encephalomyelitis. Neuroscience 189, pages 337-344.
Crossref
Crossref
Lawrence M. Samkoff & Andrew D. Goodman. (2011) Symptomatic Management in Multiple Sclerosis. Neurologic Clinics 29:2, pages 449-463.
Crossref
Crossref
Carlos Gómez-Restrepo, Laura Ospina, Sergio Castro-Díaz, Fabián Gil & Carlos Alberto Arango Villegas. (2011) Prevalencia del trastorno depresivo en pacientes que consultan un servicio de urgencias en Bogotá. Revista Colombiana de Psiquiatría 40:1, pages 22-37.
Crossref
Crossref
Ilya Kister, Ana B. Caminero, Joseph Herbert & Richard B. Lipton. (2010) Tension-type Headache and Migraine in Multiple Sclerosis. Current Pain and Headache Reports 14:6, pages 441-448.
Crossref
Crossref
Rex D. Simmons. (2010) Life issues in multiple sclerosis. Nature Reviews Neurology 6:11, pages 603-610.
Crossref
Crossref